SynthesisDrug design, development and therapy2017

Risk of severe hematologic toxicities in cancer patients treated with PARP inhibitors: a meta-analysis of randomized controlled trials.

Jian Xin Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.